According to a recent report by Fact.MR, the global lung cancer diagnostics market is anticipated to register 7.3% CAGR throughout the forecast period 2017 to 2022.
Growth of the global lung cancer diagnostics market is mainly attributed to surging developments in the lung cancer-specific biomarkers. Diagnostic tools, such as these, will facilitate personalized treatment approach for lung malignancies. ... Read more
Lung cancer is a condition, wherein the cells of the lungs divide uncontrollably, causing tumors to grow and reducing a person’s ability to breathe. According to the Centers for Disease Control, prevalence of lung cancer in the U.S. was 218,000 people in 2015. However, identification of the disease in its early stages is difficult, as its